Simple prognostic model for patients with multiple myeloma: A single-center study in Japan

Annals of Hematology

Volumn 81, Issue 1, 2002, Pages 33-36

  Kaneko, M ^a   Kanda, Y ^a,b   Oshima, K ^a   Nannya, Y ^a   Suguro, M ^a   Yamamoto, R ^a   Chizuka, A ^a   Hamaki, T ^a   Matsuyama, T ^a   Takezako, N ^a   Miwa, A ^a   Togawa, A ^a,c  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c National Hospital Organization Kofu National Hospital   (Japan)

Author keywords

Age; C reactive protein; Multiple myeloma; Multivariate analysis; Prognostic factor

Indexed keywords

ANTINEOPLASTIC AGENT; BENCE JONES PROTEIN; BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CALCIUM; CREATININE; DEXAMETHASONE; DOXORUBICIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; MELPHALAN; PARAPROTEIN; PREDNISONE; RANIMUSTINE; SERUM ALBUMIN; VINCRISTINE; VINDESINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GROUPS BY AGE; GROUPS BY SEX; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTIPLE MYELOMA; NONBIOLOGICAL MODEL; PATIENT INFORMATION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; SURVIVAL TIME; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; BETA 2-MICROGLOBULIN; C-REACTIVE PROTEIN; CREATININE; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; PLATELET COUNT; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0036942916     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-001-0388-5     Document Type: Article

References (13)

1. Alexanian R, Dimopoulos M (1994) The treatment of multiple myeloma. N Engl J Med 330:484-489
2. Bataille R, Boccadoro M, Klein B, Durie B, Pileri A (1992) C-reactive protein and β-2 microglobulin produce a simple and powerful myeloma staging system. Blood 80:733-737
3. Bataille R, Durie BG, Grenier J, Sany J (1986) Prognostic factors and staging in multiple myeloma: a reappraisal. J Clin Oncol 4:80-87
4. Durie BG, Stock-Novack D, Salmon SE, Finley P, Beckord J, Crowley J, Coltman CA (1990) Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study. Blood 75:823-830
5. Greipp PR, Lust JA, O'Fallon WM, Katzmann JA, Witzig TE, Kyle RA (1993) Plasma cell labeling index and β2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood 81:3382-3387
6. Greipp P.R, Raymond NM, Kyle RA, O'Fallon WM (1985) Multiple myeloma: significance of plasmablastic subtype in morphological classification. Blood 65:305-310
7. Kyle RA (1994) Why better prognostic factors for multiple myeloma are needed? Blood 83:1713-1716
8. Myeloma Trialists' Collaborative Group (1998) Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,663 patients from 27 randomized trials. J Clin Oncol 16:3832-3842
9. Reibnegger G, Krainer M, Herold M, Ludwig H, Wachter H, Huber H (1991) Predictive value of interleukin-6 and neopterin in patients with multiple myeloma. Cancer Res 51:6250-6253
10. Tricot G, Barlogie B, Jagannath S, Bracy D, Mattox S, Vesole DH, Naucke S, Sawyer JR (1995) Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood 86:4250-4256
11. Turesson I, Abildgaard N, Ahlgren T, Dahl IM, Holmberg E, Hjorth M, Nielsen JL, Oden A, Seidel C, Waage A, Westin J, Wilsloff F (1999) Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factors. Br J Haematol 106:1005-1012
12. Siegel DS, Desikan KR, Mehta J, Singhal S, Fassas A, Munshi N, Anaissie E, Naucke S, Ayers D, Spoon D, Vesole D, Tricot G, Barlogie B (1999) Age is not a prognostic variable with autotransplants for multiple myeloma. Blood 93:5 1-54
13. Majolino I, Vignetti M, Meloni G, Vegna ML, Scime R, Tringali S, Amaddii G, Coser P, Tribalto M, Raimondi R, Bergonzi C, Sajeva MR, Sica S, Ferrando F, Messina G ' Mandelli F (1999) Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo. Haematologica 84:844-852